Skip to main content
Addgene

Cancer-associated ASXL1 mutations may act as gain-of-function mutations of the ASXL1-BAP1 complex.

Balasubramani A, Larjo A, Bassein JA, Chang X, Hastie RB, Togher SM, Lahdesmaki H, Rao A
Nat Commun. 2015 Jun 22;6:7307. doi: 10.1038/ncomms8307. (Link opens in a new window) PubMed (Link opens in a new window) Article

Plasmids from Article

ID Plasmid Purpose
74244pCMV6-XL4 ASXL1 (1-1304)Cancer-associated ASXL1 truncation mutant in mammalian expression vector
74245pCMV6-XL4 ASXL1 (p.G646 Wfs *12) 3x FLAGCancer-associated ASXL1 truncation mutant in mammalian expression vector
74261pCMV6-XL4 ASXL1 (p.Y591X) 3x FLAGCancer-associated ASXL1 truncation mutant in mammalian expression vector
74262pCMV6-XL4 ASXL1 (1-479) 3x FLAGCancer-associated ASXL1 truncation mutant in mammalian expression vector
74263pCMV6-XL4 ASXL1 (p.R404X) 3x FLAGCancer-associated ASXL1 truncation mutant in mammalian expression vector
81021MSCV-IRES-GFP ASXL1 (p.G646 Wfs *12) 3x FLAGCancer-associated ASXL1 truncation mutant in retroviral vector
81022MSCV-IRES-GFP ASXL1 (p.Y591X) 3x FLAGCancer-associated ASXL1 truncation mutant in retroviral vector
81023MSCV-IRES-GFP ASXL1 (1-479) 3x FLAGCancer-associated ASXL1 truncation mutant in retroviral vector
81025BAP1 C91ARetroviral vector containing human BAP1 C91A (catalytically inactive mutant) and Thy1.1 selection marker

Antibodies from Article